Suhas D. Darekar
Stockholm, AB 17121, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage.
Journal: Nature communications
Published: August 18, 2023
Correction: Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells.
Journal: Cell death discovery
Published: November 30, 2022
Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells.
Journal: Cell death discovery
Published: August 18, 2022
Asymmetric inheritance of cytoophidia could contribute to determine cell fate and plasticity: The onset of alternative differentiation patterns in daughter cells may rely on the acquisition of either CTPS or IMPDH cytoophidia: The onset of alternative differentiation patterns in daughter cells may rely on the acquisition of either CTPS or IMPDH cytoophidia.
Journal: BioEssays : news and reviews in molecular, cellular and developmental biology
Published: July 01, 2022
Cell stemness is maintained upon concurrent expression of RB and the mitochondrial ribosomal protein S18-2.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 24, 2020
Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage.
Journal: Nature communications
Published: May 24, 2018
A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage.
Journal: Nature communications
Published: May 12, 2017
Rat embryonic fibroblasts immortalized by MRPS18-2 protein are target for NK-cells.
Journal: Oncotarget
Published: March 16, 2017
DNA Tumor Viruses and Cell Metabolism.
Journal: Oxidative medicine and cellular longevity
Published: November 28, 2015
Last Updated: 09/26/2026